Stephen K. Doberstein, SVP & Chief Scientific Officer at NEKTAR THERAPEUTICS (NKTR), sold 87,354 shares at $24.97 ($2.2M) on 2017-10-05, disclosed to the SEC on 2017-10-10.
Open-market sale of $2.2M NKTR by SVP & Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.97 | 43,677 | $1.1M | 50.0% |
| 2 | $24.97 | 43,677 | $1.1M | 50.0% |
| Total | $24.97 avg | 87,354 | $2.2M | 100% |
| Filing → |
| NKTR | SELL | 2019-05-17 | $217K | — | Filing → |
| NKTR | SELL | 2019-02-21 | $281K | — | Filing → |
| NKTR | SELL | 2018-11-19 | $173K | — | Filing → |